logo
Assembly Speaker Carl Heastie makes bombshell bid to reduce Gov. Hochul's power in NY budget negotiations

Assembly Speaker Carl Heastie makes bombshell bid to reduce Gov. Hochul's power in NY budget negotiations

Yahoo08-05-2025
It's Heastie versus Hochul.
State Assembly Speaker Carl Heastie is going to war with Gov. Kathy Hochul, pushing a bombshell bill Wednesday to curtail her leverage in high-stakes New York budget talks — as disagreements over her policy demands stymie the negotiations.
The Bronx Democrat introduced a bill that would allow lawmakers to continue getting paid if state budget talks drag on with no end in sight past the annual April 1 deadline to pass a spending plan.
The legislation was not introduced in the state Senate, where Deputy Majority Leader Mike Gianaris (D-Queens) — who hadn't yet reviewed Heastie's bill — said tensions were growing over Hochul's asks, including those concerning involuntary commitment and discovery law.
'I think it's born out of the frustration we all share about the continued insistence on non-budgetary policy into this budget conversation,' Gianaris said. 'We're now a week-and-a-half late and we're still getting new things dropped on the table that have nothing to do with funding the government and keeping it operative.'
Negotiations over Hochul's proposed $252 billion budget breezed past the April 1 deadline as the governor stood her ground on her bids to tweak mandates governing discovery evidence-sharing in criminal cases and to make it easier to force mentally ill people into psychiatric care.
Hochul smiled last week as she told reporters she's willing to hold up budget talks for months unless lawmakers fall in line with her demands.
And this week, Heastie's counterpart in the state Senate — Andrea Stewart-Cousins (D-Westchester) — deemed budget talks at an impasse.
'I wish I could say we're further along, but I think we are stuck at where we were last week,' Stewart-Cousins told reporters Tuesday.
Hochul's spokesperson Avi Small argued the issues holding up the budget — including tough-on-crime and mental health measures — have the overwhelming support of New Yorkers.
'If the highest-paid State Legislators in America are worried about their paychecks, there's a much easier solution: come to the table and pass a budget that includes Governor Hochul's common-sense agenda,' Small said.
The biggest policy issue causing the legislative logjam continues to be Hochul's pitch to reform the 2019 discovery law – signed by then-Gov. Andrew Cuomo – setting strict timeframes for when prosecutors are required to turn over masses of evidence to the defense in criminal cases.
City district attorneys and across the state argue the law has caused a wave of cases to be tossed over technicalities, arguing judges can be overzealous in applying a court decision that governs how evidence-sharing should work and when charges should be dismissed due to non-compliance.
Hochul wants to limit how and when cases can be tossed over a discovery violation, but lawmakers argue such changes are unnecessary because judges already have leeway to opt not to dismiss.
But another possible stumbling block in the budget negotiations — Hochul's pitch to make it easier to commit violently mentally ill people — appears to be clearing.
Heastie told reporters Tuesday that negotiators are 'close' to an agreement, which would tack on priorities from the legislature to Hochul's plan, including enhancing planning for when a person is discharged from a hospital after being committed.
The snags still evidently frustrated Heastie, whose budget delay bill – first reported by Gothamist — tries to land a punch against Hochul by effectively removing a potential pressure point on legislators.
Under the would-be law, legislators would continue pocketing a paycheck if the the budget is late and policy items have been included in the governor's proposal.
Unlike lawmakers, Empire State governors keep getting paid if the budget is late.
Hochul has held up budget talks every year since taking office in 2021 by including policy asks in her spending plan.
Heastie's bill could face a largely unprecedented uphill battle in Albany's recent memory.
The assembly has enough Democrats to pass it on its own, assuming there are no defections. The Senate, however, would need Republicans to get on board.
A two-thirds majority in both houses would be needed to override Hochul's likely veto of the bill. Democrats have not overridden a governor's veto since the party reclaimed the majority in both houses in 2019.
Lawmakers who spoke with The Post had mixed reactions to the seriousness of Heastie's bid to get them paid during the stalemate.
Some said it was unnecessary because they're willing to forgo pay.
'Not getting paid doesn't have the effect of making my colleagues hungry to get a deal,' one Assembly member said.
Gianaris said Hochul trying to turn the screws on lawmakers with delays won't work.
'This notion that somehow holding it up will allow any governor to shift blame to the legislature, it never works,' he said. 'Every governor I've served with has tried it, and it's never ever worked.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ultragenyx Pharmaceutical Inc. (RARE): A Bull Case Theory
Ultragenyx Pharmaceutical Inc. (RARE): A Bull Case Theory

Yahoo

time21 minutes ago

  • Yahoo

Ultragenyx Pharmaceutical Inc. (RARE): A Bull Case Theory

We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on Valueinvesting subreddit by bluespacecolombo. In this article, we will summarize the bulls' thesis on RARE. Ultragenyx Pharmaceutical Inc.'s share was trading at $27.61 as of July 28th. A scientist in a laboratory coat looking into a microscope at human bone regeneration samples. Ultragenyx Pharmaceutical (RARE) has seen its share price halve in just two weeks, largely due to a halted trial and an FDA rejection, but the market appears to have overreacted. The company's Phase 3 trial for setrusumab, a potential blockbuster therapy for a rare bone disease, failed to meet an early 'stop-for-efficacy' milestone, yet the study remains on track, with safety intact and final results expected in late 2025 under less stringent endpoints. Meanwhile, the FDA issued a complete response letter for another gene therapy candidate, citing manufacturing issues rather than safety or efficacy concerns. The program remains viable, with a resubmission expected once production adjustments are made. Despite these setbacks, Ultragenyx continues to generate meaningful revenue, posting $139 million in Q1 and guiding for over $640 million in 2025, and maintains a robust cash position of around $560 million, with management projecting lower cash burn. Beyond setrusumab, the company's pipeline is well diversified, featuring DTX401, a gene therapy for glycogen storage disease that met Phase 3 goals and is slated for FDA submission this year, as well as an advanced Angelman syndrome program in Phase 3. None of the recent regulatory or clinical updates involved failures of safety or efficacy, leaving the scientific foundation of the pipeline intact. Analysts' average price targets remain near $100, implying a potential threefold upside from the current ~$26 level. With solid fundamentals, multiple near-term catalysts, and a temporarily depressed valuation, Ultragenyx represents a compelling contrarian opportunity as panic-driven selling unwinds. Previously we covered a bullish thesis on Capricor Therapeutics, Inc. (CAPR) by androidmj in March 2025, which highlighted the upcoming FDA decision on Deramiocel, strong financial backing, and significant upside on approval. The company's stock has depreciated about 46.32% since then as the thesis has yet to play out. The thesis still stands given CAPR's cash runway and de-risked catalyst. bluespacecolombo shares a similar view on the biotech space but emphasizes Ultragenyx's diversified pipeline, overreaction-driven selloff, and near-term catalysts. Ultragenyx Pharmaceutical Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 55 hedge fund portfolios held RARE at the end of the first quarter which was 57 in the previous quarter. While we acknowledge the potential of RARE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Tesla Offers Musk $30 Billion to Stay--With Strings Attached
Tesla Offers Musk $30 Billion to Stay--With Strings Attached

Yahoo

time21 minutes ago

  • Yahoo

Tesla Offers Musk $30 Billion to Stay--With Strings Attached

Tesla (NASDAQ:TSLA) just handed CEO Elon Musk a massive new stock awardworth around $30 billiondesigned to keep him anchored at the helm while the company weathers legal battles and business headwinds. The package includes 96 million shares at a $23.34 exercise price, and it only kicks in if Musk stays in a senior leadership role for another two years. It's a stopgap move while the board appeals a court decision that voided his original 2018 compensation plan. That plan, once pegged at $56 billion, has become a flashpoint for investors and governance advocates alike. The interim award signals Tesla's intent to keep Musk focused during a volatile phase for the business. Tesla's board calls this a good faith gestureand timing matters. After a tough first half marked by declining sales, falling revenue, and a 25% YTD drop in share price, the company is leaning heavily on Musk's leadership to navigate what it describes as a critical inflection point. According to Wedbush analyst Dan Ives, the new agreement helps remove a lingering cloud over the stock and likely cements Musk's role for the foreseeable future. The board is also developing a longer-term pay structure, to be voted on at the November 6 shareholder meeting. But leadership retention isn't the only thing on the line. Musk's attention has been split across multiple venturesSpaceX, xAI, X Corp, Neuralink, The Boring Companyand his recent political entanglements haven't helped. The board acknowledges these distractions but says Musk remains central to Tesla's ability to attract and retain talent. Meanwhile, Tesla is trying to build momentum around its new robotaxi program, launched in Austin, which could be a long-term growth lever. Whether this compensation reset keeps Musk focused on Teslaor just buys timeis what investors will be watching next. This article first appeared on GuruFocus. Sign in to access your portfolio

Top South Dakota official apologizes for releasing voter data
Top South Dakota official apologizes for releasing voter data

Yahoo

time21 minutes ago

  • Yahoo

Top South Dakota official apologizes for releasing voter data

SIOUX FALLS, S.D. (AP) — South Dakota's top elections official has apologized for the state releasing information about voters who also were seeking public assistance, such as food aid. Secretary of State Monae Johnson made the voter registration rolls of more than 600,000 voters public last month to comply with a new state law. But the spreadsheet of voter information also included a field for source of registration, which disclosed whether an individual registered to vote at a public assistance agency, such as those offering housing help and food assistance. Federal law prohibits the government from releasing information about those receiving public assistance. The data leak drew condemnation from across the state, and the American Civil Liberties Union called it an 'egregious violation of voters' privacy rights.' Johnson apologized on Friday. 'As Secretary of State, I take full responsibility for the release of this information. My office is committed to both transparency and protecting voter privacy," Johnson said in statement. 'Upon discovering the issue, we acted immediately to remove the data and prevent further dissemination.' The information was taken off the website Friday, the day after the ACLU sent a letter to the office demanding the state fix the issue. Individuals who had their information disclosed have been notified by mail, and those with access to the information will be asked to delete it. The secretary of state also clarified that registering at a public assistance agency does not necessarily mean an individual is receiving benefits. In South Dakota, a person can register to vote at driver's license exam stations, disability service offices, military recruitment centers and county auditor offices in addition to public assistance agencies. The ACLU is now encouraging those who were impacted to fill out their legal intake form. "Essentially, voters who exercised their right to register to vote at public benefits offices were punished for it through this substantial privacy violation,' ACLU South Dakota Advocacy Manager Samantha Chapman said. South Dakota Attorney General Marty Jackley is appointing legal counsel to represent the Secretary of State's office and the state legislature in case of potential lawsuits. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store